New implant could help fight opioid addiction
Disease control
Completed
This early-stage study tested a new implant that slowly releases naltrexone, a medication used to treat opioid use disorder. The implant is placed under the skin and left for three months. The trial involved 16 healthy adults to check safety and how the drug enters the bloodstrea…
Phase: PHASE1 • Sponsor: Akyso Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC